发表论文 2022-2023学年
发布日期：2022-11-15 06:01:00 来源：
- Tang C, Jiang J, Gu Y, Liu G.,“Amending the Law for Licensing Medical Practitioners of China in 2021: A Commentary”, Halth Syst Reform, 2022 Jan 1;8(1):e2048438.
- Zhang X, Lin L, Sun X, Lei X, Liu GG, Raat H, Zeng Y., “Development and validation of the Disability Index among older adults”, J Gerontol A Biol Sci Med Sci, 2022 Mar 10:glac059.
- Qing- Hua Wang, Jie Lin, Nan Peng, Quan- Ming Wang, Melissa Li, Gordon G. Liu., “Clinical Development Success Rates for Innovative Drugs in China”, International Journal of Pharmacology, 2022, forthcoming.
- Qin Zhou, Qing He, Karen Eggleston, Gordon G Liu, “Urban-Rural Health Insurance Integration in China: Impact on Health Care Utilization, Financial Risk Protection, and Health Status”, Applied Economics, 2022, forthcoming.
- Liu GG, Wu J, He X, Jiang Y., “Policy Updates on Access to and Affordability of Innovative Medicines in China” ,Value in Health Regional Issues, 2022 Jul;30:59-66.
- 罗奇，刘猛，赵永亮.“关税消减如何影响企业存货调整？”, 《经济社会体制比较》，2022年第6期。
- Li S, Wu Z, Liu S, Sun Y, Liu GG, et al., “Effect of a brief intervention with small financial incentives on alcohol consumption in China: study protocol for a randomised controlled trial”, BMJ Open, 2022 May 18;12(5):e056550.
- Wu Z, Liang F, Chen X, Liu GG, et al.,“Hospital admission risks and ambient fine particulate matter exposure in Beijing, China”, Atmospheric Environ, 2022; 288: 119291.
- Liu Y, Hao Y, Lu ZN.,“Health shock, medical insurance and financial asset allocation: evidence from CHFS in China”, Health Econ Rev, 2022 Oct 21;12(1):52.
NSD论坛
EMAIL
北京大学
ENGLISH
